Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy

Author： Koo Sophia   Baden Lindsey R.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.6, Iss.2, 2008-02, pp. : 202-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 293-300

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Hematologic Malignancies: Radiation Dosimetry Aspects

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-01 ,pp. : 351-356

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal antibodies for prophylaxis and therapy of infectious diseases

By Meulen Jan ter  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 525-540

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4858-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite